Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Annals of Physical and Rehabilitation Medicine|October 16, 2012
What is the best support surface in prevention and treatment, as of 2012, for a patient at risk and/or suffering from pressure ulcer sore? Developing French guidelines for clinical practiceD Colin, J-M Rochet, P Ribinik, et al.
Annals of Physical and Rehabilitation Medicine|October 2, 2012
What is the role of TPE in management of patients at risk or with pressure ulcer as of 2012? Developing French guidelines for clinical practiceA Gelis, S Pariel, D Colin, et al.
Annals of Physical and Rehabilitation Medicine|October 16, 2012
Which medical technology and/or local treatment is most conducive, as of 2012, to pressure sore debridement ? Developing French guidelines for clinical practiceC Trial, J Pineau, B Barrois, et al.
Journal of Wound Care|October 7, 2008
A national prevalence study of pressure ulcers in French hospital inpatientsB Barrois, C Labalette, P Rousseau, et al.
Annals of Physical and Rehabilitation Medicine|October 13, 2012
Which medical device and/or which local treatment are to be used, as of 2012, in patients with infected pressure sore? Developing French guidelines for clinical practiceH Arzt, I Fromantin, P Ribinik, et al.
Annals of Physical and Rehabilitation Medicine|October 2, 2012
Which medical device and/or which local treatment for prevention in patients with risk factors for pressure sores in 2012? Developing French guidelines for clinical practiceB Nicolas, A S Moiziard, B Barrois, et al.
Annals of Physical and Rehabilitation Medicine|October 2, 2012
Which medical devices and/or local drug should be curatively used, as of 2012, for PU patients? How can granulation and epidermidalization be promoted? Developing French guidelines for clinical practiceB Nicolas, A S Moiziard, B Barrois, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Cyclic lipopeptide natural products as taxa-specific antibacterial inhibitors of the lipid II flippaseElizabeth B Barrois, Jonas H Costa-Martini, Lina Thoma, et al.
Pageof 2